NEAT1 was reported to serve as a “sponge” of miR-101 to promote the progression and radio-resistance of some types of cancer, including non-small cell lung cancer, hepatocellular carcinoma, papillary thyroid carcinoma, breast cancer and nasopharyngeal carcinoma 25-29. Here, NEAT1 is linked to cancer.